A detailed history of Andesa Financial Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Andesa Financial Management Inc. holds 5,926 shares of ABBV stock, worth $1.05 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,926
Previous 5,081 16.63%
Holding current value
$1.05 Million
Previous $821,000 14.98%
% of portfolio
0.28%
Previous 0.45%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $122,195 - $140,726
845 Added 16.63%
5,926 $944,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $54,770 - $65,684
-396 Reduced 7.23%
5,081 $821,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $98,644 - $113,138
735 Added 15.5%
5,477 $735,000
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $46,928 - $59,661
341 Added 7.75%
4,742 $726,000
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $103,604 - $128,543
-785 Reduced 15.14%
4,401 $716,000
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $35,129 - $44,449
327 Added 6.73%
5,186 $702,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $65,648 - $74,521
617 Added 14.55%
4,859 $522,000
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $46,081 - $51,337
-438 Reduced 9.36%
4,242 $477,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $6,649 - $7,320
65 Added 1.41%
4,680 $506,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $13,200 - $17,821
164 Added 3.68%
4,615 $496,000
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $147,937 - $173,629
1,722 Added 63.1%
4,451 $390,000
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $200,226 - $267,933
2,729 New
2,729 $268,000
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $333,479 - $400,937
-5,295 Closed
0 $0
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $3.32 Million - $4.24 Million
-50,485 Reduced 90.51%
5,295 $385,000
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $2.55 Million - $3.01 Million
33,101 Added 145.95%
55,780 $4.49 Million
Q4 2018

Jan 24, 2019

BUY
$77.85 - $96.01 $1.06 Million - $1.3 Million
13,589 Added 149.49%
22,679 $2.09 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $1.21 Million - $1.35 Million
-13,609 Reduced 59.95%
9,090 $857,000
Q2 2018

Sep 18, 2018

BUY
$89.78 - $106.23 $19,751 - $23,370
220 Added 0.98%
22,699 $2.1 Million
Q1 2018

Sep 18, 2018

SELL
$92.01 - $123.21 $90,905 - $121,731
-988 Reduced 4.21%
22,479 $2.13 Million
Q4 2017

Sep 18, 2018

BUY
$89.56 - $98.21 $2.1 Million - $2.3 Million
23,467
23,467 $2.27 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Andesa Financial Management Inc. Portfolio

Follow Andesa Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andesa Financial Management Inc. with notifications on news.